[Serotonergic disturbance in hereditary progressive dystonia--clinical effects of tetrahydrobiopterin and 5-hydroxytryptophan].
Ishida
A
A
Takada
G
G
Kobayashi
Y
Y
Higashi
O
O
Toyoshima
I
I
Takai
K
K
D006916:5-Hydroxytryptophan / Q000627:therapeutic use*; D000328:Adult; D001708:Biopterins / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002648:Child; D004298:Dopamine / Q000378:metabolism; D004421:Dystonia / Q000188:drug therapy / Q000235:genetics*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009474:Neurons / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism*
D001708:Biopterins; D012701:Serotonin; D007980:Levodopa; D006916:5-Hydroxytryptophan; C003402:sapropterin; D004298:Dopamine